CFGS
SUPN icon

Concourse Financial Group Securities’s Supernus Pharmaceuticals SUPN Stock Holding History

Concourse Financial Group Securities’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-24
Closed -$916 – 1814
2024
Q4 		$916 Buy
24
+2
+9% +$70 ﹤0.01% 2109
2024
Q3 		$685 Sell
22
-3
-12% -$94 ﹤0.01% 2110
2024
Q2 		$668 Sell
25
-2
-7% -$58 ﹤0.01% 2170
2024
Q1 		$920 Buy
27
+16
+145% +$476 ﹤0.01% 2147
2023
Q4 		$318 Sell
11
-5
-31% -$133 ﹤0.01% 2221
2023
Q3 		$441 Sell
16
-12
-43% -$365 ﹤0.01% 2198
2023
Q2 		$841 Sell
28
-3
-10% -$105 ﹤0.01% 2159
2023
Q1 		$1.12K Hold
31
– – ﹤0.01% 2148
2022
Q4 		$1.1K Buy
31
+2
+7% +$70 ﹤0.01% 2152
2022
Q3 		$1K Buy
+29
New +$944 ﹤0.01% 1931
2019
Q4 		– Sell
-52
Closed -$1.26K – 2132
2019
Q3 		$1K Sell
52
-28
-35% -$830 ﹤0.01% 1692
2019
Q2 		$3K Sell
80
-17
-18% -$582 ﹤0.01% 1924
2019
Q1 		$3K Sell
97
-19
-16% -$707 ﹤0.01% 1949
2018
Q4 		$3K Buy
116
+40
+53% +$1.72K ﹤0.01% 1853
2018
Q3 		$4K Buy
+76
New +$3.75K ﹤0.01% 1475

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Concourse Financial Group Securities's SUPN Position: Q1 2025 in Review

Concourse Financial Group Securities sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 24 shares — an estimated $916 sold.

Concourse Financial Group Securities first reported a position in SUPN in Q3 2018 and held it in 15 quarters. The position peaked at $4K in Q3 2018. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Concourse Financial Group Securities reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Concourse Financial Group Securities sold 24 Supernus Pharmaceuticals shares in Q1 2025, an estimated $916.
  • Concourse Financial Group Securities first reported a position in Supernus Pharmaceuticals in Q3 2018 and held it in 15 quarters.
  • Concourse Financial Group Securities's Supernus Pharmaceuticals position peaked at $4K in Q3 2018.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Concourse Financial Group Securities's 13F filing for Q1 2025.